These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 19330649)
1. Interleukin-6-independent expression of glucocorticoid receptor is upregulated by triptolide in multiple myeloma. Yang M; Shen JK; Huang J; Du HP; Ma QL; Jin J Leuk Lymphoma; 2009 May; 50(5):802-8. PubMed ID: 19330649 [TBL] [Abstract][Full Text] [Related]
2. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells. Yang M; Huang J; Pan HZ; Jin J Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856 [TBL] [Abstract][Full Text] [Related]
3. Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs. Huang X; Yang M; Jin J Leuk Lymphoma; 2012 Jun; 53(6):1188-95. PubMed ID: 22260163 [TBL] [Abstract][Full Text] [Related]
4. Triptolide blocks the STAT3 signaling pathway through induction of protein tyrosine phosphatase SHP-1 in multiple myeloma cells. Kim JH; Park B Int J Mol Med; 2017 Nov; 40(5):1566-1572. PubMed ID: 28901387 [TBL] [Abstract][Full Text] [Related]
5. Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1. Nakazato T; Sagawa M; Kizaki M Int J Oncol; 2014 Apr; 44(4):1131-8. PubMed ID: 24481531 [TBL] [Abstract][Full Text] [Related]
6. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells. Yinjun L; Jie J; Yungui W Leuk Res; 2005 Jan; 29(1):99-105. PubMed ID: 15541481 [TBL] [Abstract][Full Text] [Related]
7. Effects of triptolide on RIZ1 expression, proliferation, and apoptosis in multiple myeloma U266 cells. Zhao F; Chen Y; Zeng LL; Li R; Zeng R; Wen L; Liu Y; Zhang C Acta Pharmacol Sin; 2010 Jun; 31(6):733-40. PubMed ID: 20523343 [TBL] [Abstract][Full Text] [Related]
8. Triptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B. Wen L; Chen Y; Zeng LL; Zhao F; Li R; Liu Y; Zhang C Acta Pharmacol Sin; 2012 Jan; 33(1):109-19. PubMed ID: 22120968 [TBL] [Abstract][Full Text] [Related]
9. Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44. Yi JM; Huan XJ; Song SS; Zhou H; Wang YQ; Miao ZH Mol Cancer Ther; 2016 Jul; 15(7):1495-503. PubMed ID: 27197304 [TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells. Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088 [TBL] [Abstract][Full Text] [Related]
11. Triptolide-induced apoptosis by inactivating nuclear factor-kappa B apoptotic pathway in multiple myeloma in vitro. Zeng R; Zeng L; Chen Y; Zhao F; Li R; Wen L; Zhang C J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):446. PubMed ID: 21823003 [TBL] [Abstract][Full Text] [Related]
12. [Effects of triptolide on bortezomib-induced apoptosis in multiple myeloma cells]. Yang Y; Dong HJ; Gao GX; Wang YW; Gu HT; Chen XQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):335-8. PubMed ID: 22541093 [TBL] [Abstract][Full Text] [Related]
13. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53. Matsui Y; Watanabe J; Ikegawa M; Kamoto T; Ogawa O; Nishiyama H Oncogene; 2008 Jul; 27(33):4603-14. PubMed ID: 18391982 [TBL] [Abstract][Full Text] [Related]
14. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma. Thomas AL; Coarfa C; Qian J; Wilkerson JJ; Rajapakshe K; Krett NL; Gunaratne PH; Rosen ST Nucl Recept Signal; 2015; 13():e006. PubMed ID: 26715915 [TBL] [Abstract][Full Text] [Related]
15. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer. Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407 [TBL] [Abstract][Full Text] [Related]
16. Dexamethasone reverses glucocorticoid receptor RNA depression in multi-drug resistant (MDR) myeloma cell lines. Danel-Moore L; Brönnegard M; Gustafsson JA Med Oncol Tumor Pharmacother; 1992; 9(4):199-204. PubMed ID: 1342065 [TBL] [Abstract][Full Text] [Related]
17. Overcoming glucocorticoid resistance: a new pathway from an ancient Chinese medicine? Krett N; Ma S Leuk Lymphoma; 2009 May; 50(5):689-90. PubMed ID: 19330651 [No Abstract] [Full Text] [Related]
18. [Effects of triptolide on the apoptosis and H3K4 protein methylation in multiple myeloma cells]. Xu CB; Liao B; Shen JZ; Fu HY; Lin T Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):450-455. PubMed ID: 29926592 [TBL] [Abstract][Full Text] [Related]
19. [Effect of triptolide on the proliferation and apoptosis of human epidermal squamous cell carcinoma cell line A431 in vitro]. Chen M; Tan S; Zhang G; Yi M; Jian D; Xie H; Chen X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 34(7):638-41. PubMed ID: 19648677 [TBL] [Abstract][Full Text] [Related]
20. MAPKs are not involved in triptolide-induced cell growth inhibition and apoptosis in prostate cancer cell lines with different p53 status. Li W; Liu Y; Li XX; Yu Y; Wu JJ; Wang Q; Huo H; Wang LM; Yang L Planta Med; 2011 Jan; 77(1):27-31. PubMed ID: 20607649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]